B. Riley Financial Lowers KindlyMD (NASDAQ:NAKA) Price Target to $0.50

KindlyMD (NASDAQ:NAKA) had its price target lowered by equities research analysts at B. Riley Financial from $1.00 to $0.50 in a research report issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. B. Riley Financial’s price target would indicate a potential upside of 114.87% from the stock’s current price.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a report on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $4.25.

KindlyMD Trading Down 4.1%

NASDAQ NAKA traded down $0.01 during trading hours on Monday, reaching $0.23. The company’s stock had a trading volume of 2,973,248 shares, compared to its average volume of 5,735,379. The business has a 50-day simple moving average of $0.37 and a 200 day simple moving average of $2.05. KindlyMD has a 52 week low of $0.23 and a 52 week high of $34.77. The stock has a market cap of $102.35 million, a PE ratio of -0.21 and a beta of 31.48.

Institutional Investors Weigh In On KindlyMD

Several large investors have recently made changes to their positions in the company. Alyeska Investment Group L.P. bought a new stake in shares of KindlyMD during the fourth quarter valued at approximately $8,993,000. ParaFi Capital LP acquired a new stake in KindlyMD in the 3rd quarter valued at approximately $443,055,000. Hunting Hill Global Capital LLC bought a new stake in KindlyMD during the 4th quarter valued at $4,672,000. RK Capital Management LLC FL bought a new stake in KindlyMD during the 3rd quarter valued at $239,052,000. Finally, Yorkville Advisors Global LP acquired a new position in KindlyMD during the 3rd quarter worth $231,942,000.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.